(Q36993678)

17 August 2017

1 reference

title

Depression and erectile dysfunction. (English)

1 reference

17 August 2017

Antoine Makhlouf

1

1 reference

PubMed ID

17983896

17 August 2017

Ashay Kparker

series ordinal

2

1 reference

PubMed ID

17983896

17 August 2017

Craig S Niederberger

series ordinal

3

1 reference

17 August 2017

1 November 2007

1 reference

Urologic Clinics of North America

17 August 2017

1 reference

17 August 2017

34

1 reference

17 August 2017

4

1 reference

17 August 2017

565-74, vii

1 reference

The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Increased incidence of depressive symptoms in men with erectile dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

The DSFI: a multidimensional measure of sexual functioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Assessment of sexual function, interest and activity in depressed men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Sexual function in depressed men. Assessment by self-report, behavioral, and nocturnal penile tumescence measures before and after treatment with cognitive behavior therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Assessment of sexual function in depressed, impotent, and healthy men: factor analysis of a Brief Sexual Function Questionnaire for men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Biological Symptoms of Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Sexual dysfunctions in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Psychopathology in individuals with sexual dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Nocturnal penile tumescence is diminished in depressed men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Reversible loss of nocturnal penile tumescence during depression: a preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Studies of nocturnal penile tumescence and sleep electroencephalogram in patients with major depression and in normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

The criterion validity of the Center for Epidemiological Studies Depression Scale (CES-D) in a sample of self-referred elders with depressive symptomatology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Prevalence of erectile dysfunction and active depression: an analytic cross-sectional study of general medical patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Depressed affect and male sexual arousal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Sexual and emotional variables influencing sexual response to erotica: a psychophysiological investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Neuroanatomical correlates of visually evoked sexual arousal in human males.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Testosterone replacement therapy for older men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Increased incidence of diagnosed depressive illness in hypogonadal older men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Low testosterone levels in elderly men with dysthymic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Effects of Medical or Surgical Castration on Erectile Function in an Animal Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Delayed testosterone replacement restores nitric oxide synthase-containing nerve fibres and the erectile response in rat penis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Restorative increases in serum testosterone levels are significantly correlated to improvements in sexual functioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Beneficial sexual side-effects from fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Sexual dysfunction before antidepressant therapy in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Prevalence of sexual dysfunction among newer antidepressants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

The psychopharmacology of sex, Part 1: Neurotransmitters and the 3 phases of the human sexual response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

A randomized, placebo-controlled, crossover study of ephedrine for SSRI-induced female sexual dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

On-demand SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and consequent solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Dopamine and serotonin: influences on male sexual behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

DA-8159 reverses selective serotonin reuptake inhibitor-induced erectile dysfunction in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Vardenafil reverses erectile dysfunction induced by paroxetine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Inpatient treatment of depression and associated hospital charges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Accommodation to serotonin reuptake inhibitor-induced sexual dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Antidepressant discontinuation syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Withdrawing drugs: nefazodone, the start of the latest saga

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Sexual functioning in depressed outpatients taking mirtazapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Improvements in SSRI/SNRI-induced sexual dysfunction by switching to escitalopram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Bupropion: pharmacology and therapeutic applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Sildenafil treatment of serotonin reuptake inhibitor-induced sexual dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Phosphodiesterase type 5 inhibitors for erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Tadalafil for treatment of erectile dysfunction in men on antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

Economic analysis of sildenafil citrate (Viagra) add-on to treat erectile dysfunction associated with selective serotonin reuptake inhibitor use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

The Gotland Male Depression Scale: a validity study in patients with alcohol use disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2007.08.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UCL.2007.08.009

1 reference

17 August 2017

1 reference

PubMed ID

17983896